Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How the rich get richer

Mike Rossner, Ira Mellman

    The Journal of Cell Biology
    |June 15, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity.

    Proceedings of the National Academy of Sciences of the United States of America·2026
    Same author

    Clonal hematopoiesis is associated with reduced response to atezolizumab in non-small cell lung cancer.

    Journal for immunotherapy of cancer·2025
    Same author

    RNA neoantigen vaccines prime long-lived CD8<sup>+</sup> T cells in pancreatic cancer.

    Nature·2025
    Same author

    Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.

    Cancer immunology research·2025
    Same author

    Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.

    Nature cancer·2025
    Same author

    Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.

    Nature medicine·2025